TUESDAY, April 4, 2023 (HealthDay News) — Imagine a perfect week at work. Everything runs smoothly, and you love your job. Sounds like a dream, doesn’t it? While those days are possible, work can also be a source of frequent and intense stress. Let’s face it, work stress is unavoidable.Continue Reading

MONDAY, April 3, 2023 (HealthDay News) — An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says. Ficlatuzumab used in combination with the already approved targeted drug cetuximab (Erbitux) significantly improvedContinue Reading